Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways

Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers

(2010) R. Hassan et al.   CLINICAL CANCER RESEARCH

p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients

(2010) M. K. Y. Siu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway

(2009) Ming-Cheng Chang et al.   BIOCHEMICAL JOURNAL

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma

(2009) W-F Cheng et al.   BRITISH JOURNAL OF CANCER

Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A, a Novel  -Catenin/TCF Target Gene

(2008) K. Ganesan et al.   CANCER RESEARCH

p21Waf1/Cip1 Expression by Curcumin in U-87MG Human Glioma Cells: Role of Early Growth Response-1 Expression

(2008) B. H. Choi et al.   CANCER RESEARCH

Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor

(2008) Yira Bermudez et al.   GROWTH FACTORS

Mesothelin Promotes Anchorage-Independent Growth and Prevents Anoikis via Extracellular Signal-Regulated Kinase Signaling Pathway in Human Breast Cancer Cells

(2008) N. Uehara et al.   MOLECULAR CANCER RESEARCH